文献速递乳房整形与再造美容整形

1000例乳房切除术后脂肪移植乳房再造的肿瘤学结局:单中心配对病例对照研究

Oncologic Outcome of 1000 Postmastectomy Breast Reconstructions with Fat Transfer: A Single-Center, Matched Case-Control Study.
PubMed 文献 · Plast Reconstr Surg · 2022-09-28

该单中心配对病例对照研究纳入2005至2017年902例患者共1025例乳房再造,经1:n配对后分析919例乳房,其中425例(46.2%)接受至少一次自体脂肪移植,494例(53.8%)为对照。局部复发总体发生率为6.8%,脂肪移植组14例(3.0%),对照组54例(9.6%);结论认为脂肪移植与局部区域复发概率升高无关,可安全用于全乳再造或美学修整。

要点

  • 脂肪移植组局部复发14例(3.0%),对照组54例(9.6%),总体复发率6.8%。
  • 浸润性导管癌亚型与淋巴结转移与局部复发风险升高相关(HR>1),激素受体阳性与风险降低相关(HR<1)。

核心结论

  • 自体脂肪移植与乳房再造患者局部区域复发概率升高无关,可安全用于全乳再造或美学修整。

研究设计与样本

  • 单中心配对病例对照研究,数据来自前瞻性维护数据库,纳入2005至2017年902例患者共1025例乳房再造。
  • 排除初诊时远处转移、肿瘤复发、原发肿瘤数据不完整、预防性乳房切除及保乳手术患者。
  • 经1:n配对后选取919例乳房,脂肪移植组425例(46.2%),对照组494例(53.8%)。
  • 采用统计学分析评估各变量对局部复发发生率的影响,P<0.05为差异有统计学意义。

主要发现

  • 局部复发总体发生率为6.8%,脂肪移植组14例(3.0%),对照组54例(9.6%)。
  • 多因素分析显示浸润性导管癌亚型与淋巴结转移与局部复发风险升高相关(HR>1)。
  • 激素受体阳性与局部复发风险降低相关(HR<1)。

关键数值与推荐

  • 局部复发总体发生率6.8%,脂肪移植组3.0%(14例) vs 对照组9.6%(54例)。
  • 证据等级:风险,II级。

临床怎么用

  • 作者认为自体脂肪移植可安全用于全乳再造或美学修整。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autologous fat transfer has an important role in breast reconstructive surgery. Nevertheless, some concerns remain with regard to its oncologic safety. The authors present a single-center, case-matching study analyzing the impact of autologous fat transfer in the cumulative incidence of local recurrences. METHODS: From a prospectively maintained database, the authors identified 902 patients who underwent 1025 breast reconstructions from 2005 to 2017. Data regarding demographics, tumor characteristics, surgery details, and follow-up were collected. Exclusion criteria were patients with distant metastases at diagnosis, recurrent tumor, or incomplete data regarding primary tumor; and patients who underwent prophylactic mastectomies and breast-conserving operations. Statistical analysis was conducted to evaluate the impact of the variables on the incidence of local recurrence. A value of p < 0.05 was considered statistically significant. RESULTS: After 1: n case-matching, we selected 919 breasts, of which 425 patients (46.2 percent) received at least one autologous fat transfer session versus 494 control cases (53.8 percent). Local recurrences had an overall rate of 6.8 percent, and we found local recurrences in 14 autologous fat transfer cases (3.0 percent) and 54 controls (9.6 percent). Statistical analysis showed that autologous fat transfer did not increase the risk of local recurrences (hazard ratio, 0.337; CI, 0.173 to 0.658; p = 0.00007). Multivariate analysis identified invasive ductal carcinoma subtype and lymph node metastases to have an increased risk of local recurrences (hazard ratio >1). Conversely, positive hormonal receptor status was associated with a reduced risk of events (hazard ratio <1). CONCLUSIONS: Autologous fat transfer was not associated with a higher probability of locoregional recurrence in patients undergoing breast reconstruction; therefore, it can be safely used for total breast reconstruction or aesthetic refinements. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Sorotos M, Paolini G, D'Orsi G, et al. Oncologic Outcome of 1000 Postmastectomy Breast Reconstructions with Fat Transfer: A Single-Center, Matched Case-Control Study. Plast Reconstr Surg. 2022. PMID: 35943964. doi:10.1097/PRS.0000000000009494

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。